San Diego-based biotechnology company developing therapies and partnering with biopharma using a proprietary patient-based ex vivo disease biology platform
San Diego-based biotechnology company developing therapies and partnering with biopharma using a proprietary patient-based ex vivo disease biology platform. It combines functional data with single-cell, spatial, and other multi-omic profiles to identify druggable targets, initially focused on immuno-oncology and the tumor microenvironment.